Valuation: Yuhan Corporation

Market Cap 5,587B 3.83B 3.36B 3.12B 2.87B 5.39B 368B 5.47B 37.11B 14.5B 181B 14.36B 14.05B 626B P/E 2026 *
41.1x
P/E 2027 * 26.9x
Enterprise Value 5.5B 3.77M 3.31M 3.08M 2.82M 5.3M 363M 5.38M 36.52M 14.27M 178M 14.13M 13.83M 616M EV / Sales 2026 *
2.36x
EV / Sales 2027 * 2.1x
Free-Float
64.28%
Yield 2026 *
0.74%
Yield 2027 * 0.75%
1 day+4.90%
1 week+5.79%
Current month+6.70%
1 month+5.05%
3 months-20.99%
6 months-30.78%
Current year-33.36%
1 week 67,900
Extreme 67900
77,100
1 month 66,200
Extreme 66200
77,100
Current year 65,000
Extreme 65000
115,900
1 year 65,000
Extreme 65000
129,200
3 years 52,285.71
Extreme 52285.7143
166,900
5 years 47,571.43
Extreme 47571.4286
166,900
10 years 24,550.49
Extreme 24550.4865
166,900
Manager TitleAgeSince
Chief Executive Officer 71 2021-03-18
Director of Finance/CFO 58 -
President 67 2024-03-14
Director TitleAgeSince
Chairman 74 2021-03-18
Director/Board Member 71 2015-03-19
Director/Board Member 59 2021-03-18
Date Insider Type Main position Quantity % Market Cap.
6/30/25 Buy

Chairperson

200 0.0002%
6/25/25 Buy

Chief Executive Officer

720 0.0009%
6/24/25 Buy 231 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+4.90%+5.79%-38.81%+23.85% 3.83B
+0.45%+2.80%+54.73%+21.89% 324B
-0.07%+2.09%+23.58%-11.37% 68.88B
+1.35%+5.29%+40.68%+91.38% 9.72B
+0.93%-1.38%+2.01%-3.34% 8.37B
+1.13%+1.51%-21.44%-1.35% 4.32B
-4.00%+0.71%-5.66%+13.37% 3.62B
-2.10%-3.83%+37.58%+52.58% 2.68B
-4.07%-2.45%-8.03%-16.98% 2.04B
-5.78%+0.89%-16.30%+27.60% 1.84B
Average -0.73%+0.91%+6.83%+19.76% 42.9B
Weighted average by Cap. +0.34%+2.15%+45.56%+17.38%

Financials

2026 *2027 *
Net sales 2,333B 1.6B 1.4B 1.3B 1.2B 2.25B 154B 2.28B 15.49B 6.05B 75.63B 6B 5.87B 261B 2,586B 1.77B 1.56B 1.45B 1.33B 2.49B 171B 2.53B 17.18B 6.71B 83.84B 6.65B 6.5B 290B
Net income 143B 97.92M 86M 79.98M 73.39M 138M 9.43B 140M 950M 371M 4.64B 368M 360M 16.03B 212B 145M 128M 119M 109M 205M 14B 208M 1.41B 551M 6.88B 546M 534M 23.8B
Net Debt -88.37B -60.51M -53.15M -49.43M -45.36M -85.22M -5.83B -86.53M -587M -229M -2.87B -227M -222M -9.91B -166B -114M -100M -93.01M -85.34M -160M -10.97B -163M -1.1B -431M -5.39B -427M -418M -18.64B
Logo Yuhan Corporation
Yuhan Corp is a Korea-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through three segments. The Pharmaceutical Business segment manufactures and sells non-prescription drugs, such as analgesics, anti-inflammatory drugs, probiotics, nutritional supplements, and wound-healing agents, as well as prescription drugs, including treatments for diabetes, hyperlipidemia, hypertension, hepatitis, acquired immunodeficiency syndrome (AIDS), bone marrow cancer, cough suppressants, and breast cancer. The Overseas Business segment engages in the export of AIDS treatment intermediates. The Healthcare Business segment provides household goods, such as bleach. Additionally, the Company sells licenses. The Company sells its products in both domestic and overseas markets.
Employees
2,087
Date Price Change Volume
26-07-24 ₩74,900.00 +4.90% 454,629
26-07-23 ₩71,400.00 +1.71% 197,578
26-07-22 ₩70,200.00 +0.86% 255,879
26-07-21 ₩69,600.00 +0.58% 185,984
26-07-20 ₩69,200.00 -2.26% 178,034
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
74,900.00KRW
Average target price
127,555.56KRW
Spread / Average Target
+70.30%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A000100 Stock